Labcorp: Is The Innovative Testing & Specialty Growth Here To Stay?

Laboratory Corporation of America Holdings (Labcorp) reported strong financial results for the second quarter of 2025. The company delivered double-digit top-line growth, with total revenue reaching $3.5 billion, representing a 10% increase compared to the previous year. This growth was driven by both its Diagnostic Laboratories and Biopharma Laboratory Services (BLS) segments. The Diagnostics segment contributed $2.7 billion in revenue with a 9% increase, fueled equally by organic growth and acquisitions. The BLS segment saw revenues of $785 million, marking an 11% growth, or 8% in constant currency terms.